Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 2875
Gene Symbol: GPT
GPT
0.010 Biomarker disease BEFREE <b>Objective:</b> The purpose of this study was to assess the management and clinical outcome of acne patients with abnormal aspartate transaminase (AST) and alanine aminotransferase (ALT) when receiving isotretinoin. 31498706 2019
Entrez Id: 7124
Gene Symbol: TNF
TNF
0.060 GeneticVariation disease BEFREE Tumor necrosis factor-α -308 G/A and interleukin 10 -1082 A/G gene polymorphisms in patients with acne vulgaris. 22835835 2012
Entrez Id: 6662
Gene Symbol: SOX9
SOX9
0.010 Biomarker disease BEFREE Sox9 immunostaining was increased in mature sebocytes of acne lesion compared with normal skin. 27771230 2017
Entrez Id: 114548
Gene Symbol: NLRP3
NLRP3
0.310 GeneticVariation disease BEFREE A dual luciferase reporter assay was performed to determine whether the SNP rs10754558 might be responsible for the altered NLRP3 gene expression in AV by disrupting the interaction between micro-RNA (miR)-4273 and NLRP3 mRNA. 29888470 2019
Entrez Id: 7077
Gene Symbol: TIMP2
TIMP2
0.010 GeneticVariation disease BEFREE Although no association was found between the TIMP-2 (-418G/C) polymorphism and the acne vulgaris, patients with the MMP-2 CT/TIMP-2 GG or GC allele are at higher risk of acne vulgaris. 31032338 2019
Entrez Id: 4313
Gene Symbol: MMP2
MMP2
0.010 GeneticVariation disease BEFREE Although no association was found between the TIMP-2 (-418G/C) polymorphism and the acne vulgaris, patients with the MMP-2 CT/TIMP-2 GG or GC allele are at higher risk of acne vulgaris. 31032338 2019
Entrez Id: 367
Gene Symbol: AR
AR
0.040 Biomarker disease BEFREE Androgens acting through the AR play a crucial role in the pathogenesis of acne vulgaris. 19218788 2009
Entrez Id: 3552
Gene Symbol: IL1A
IL1A
0.050 AlteredExpression disease BEFREE As part of the SICS, this study was conducted to evaluate the association between the incidence of acne vulgaris in SM-exposed subjects (20 years after the exposure) and serum levels of proinflammatory cytokines (IL-1α, IL-1β, IL-1Ra, IL-6, IL-8, IL-12 and RANTES) in an attempt to better understand the pathogenesis of long-term skin disorders of these individuals. 28193081 2017
Entrez Id: 3553
Gene Symbol: IL1B
IL1B
0.050 AlteredExpression disease BEFREE As part of the SICS, this study was conducted to evaluate the association between the incidence of acne vulgaris in SM-exposed subjects (20 years after the exposure) and serum levels of proinflammatory cytokines (IL-1α, IL-1β, IL-1Ra, IL-6, IL-8, IL-12 and RANTES) in an attempt to better understand the pathogenesis of long-term skin disorders of these individuals. 28193081 2017
Entrez Id: 3569
Gene Symbol: IL6
IL6
0.030 AlteredExpression disease BEFREE As part of the SICS, this study was conducted to evaluate the association between the incidence of acne vulgaris in SM-exposed subjects (20 years after the exposure) and serum levels of proinflammatory cytokines (IL-1α, IL-1β, IL-1Ra, IL-6, IL-8, IL-12 and RANTES) in an attempt to better understand the pathogenesis of long-term skin disorders of these individuals. 28193081 2017
Entrez Id: 3576
Gene Symbol: CXCL8
CXCL8
0.030 AlteredExpression disease BEFREE As part of the SICS, this study was conducted to evaluate the association between the incidence of acne vulgaris in SM-exposed subjects (20 years after the exposure) and serum levels of proinflammatory cytokines (IL-1α, IL-1β, IL-1Ra, IL-6, IL-8, IL-12 and RANTES) in an attempt to better understand the pathogenesis of long-term skin disorders of these individuals. 28193081 2017
Entrez Id: 6352
Gene Symbol: CCL5
CCL5
0.010 AlteredExpression disease BEFREE As part of the SICS, this study was conducted to evaluate the association between the incidence of acne vulgaris in SM-exposed subjects (20 years after the exposure) and serum levels of proinflammatory cytokines (IL-1α, IL-1β, IL-1Ra, IL-6, IL-8, IL-12 and RANTES) in an attempt to better understand the pathogenesis of long-term skin disorders of these individuals. 28193081 2017
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.020 GeneticVariation disease BEFREE Association between leptin gene rs7799039 polymorphism and lipid profile changes induced by isotretinoin treatment in acne patients. 29872305 2018
Entrez Id: 7124
Gene Symbol: TNF
TNF
0.060 GeneticVariation disease BEFREE Association study of tumor necrosis factor receptor type 2 M196R and toll-like receptor 2 Arg753Gln polymorphisms with acne vulgaris in a Chinese Han ethnic group. 20861605 2010
Entrez Id: 7421
Gene Symbol: VDR
VDR
0.010 GeneticVariation disease BEFREE Associations among two vitamin D receptor (VDR) gene polymorphisms (ApaI and TaqI) in acne vulgaris: A pilot susceptibility study. 30220112 2019
Entrez Id: 7124
Gene Symbol: TNF
TNF
0.060 GeneticVariation disease BEFREE Carriage of the GAG haplotype of TNF is linked with borderline susceptibility to acne vulgaris. 24334867 2014
Entrez Id: 367
Gene Symbol: AR
AR
0.040 Biomarker disease BEFREE Clascoterone (cortexolone 17α-propionate, CB-03-01) 1% cream, a topical, androgen receptor (AR) inhibitor under investigation for the treatment of acne vulgaris, is rapidly metabolized to cortexolone in human plasma. 31251549 2019
Entrez Id: 653499
Gene Symbol: LGALS7B
LGALS7B
0.010 Biomarker disease BEFREE Clinical significance of neutrophil gelatinase-associated lipocalin and galectin-7 in tape-stripped stratum corneum of acne vulgaris. 29473202 2018
Entrez Id: 3963
Gene Symbol: LGALS7
LGALS7
0.010 Biomarker disease BEFREE Clinical significance of neutrophil gelatinase-associated lipocalin and galectin-7 in tape-stripped stratum corneum of acne vulgaris. 29473202 2018
Entrez Id: 1672
Gene Symbol: DEFB1
DEFB1
0.020 Biomarker disease BEFREE Comparison of Efficacy of Doxycycline and Isotretinoin on Cutaneous Human Beta-Defensin-1 and -2 Levels in Acne Vulgaris. 30210158 2019
Entrez Id: 1673
Gene Symbol: DEFB4A
DEFB4A
0.020 Biomarker disease BEFREE Cutaneous expression of the AMPs cathelicidin, human β-defensin-2 (HBD-2), lactoferrin, lysozyme, psoriasin (S100A7), koebnerisin (S100A15), and RNase 7 was upregulated in untreated acne vulgaris, whereas α-defensin-1 (HNP-1) was downregulated compared to controls. 24916439 2014
Entrez Id: 100289462
Gene Symbol: DEFB4B
DEFB4B
0.020 Biomarker disease BEFREE Cutaneous expression of the AMPs cathelicidin, human β-defensin-2 (HBD-2), lactoferrin, lysozyme, psoriasin (S100A7), koebnerisin (S100A15), and RNase 7 was upregulated in untreated acne vulgaris, whereas α-defensin-1 (HNP-1) was downregulated compared to controls. 24916439 2014
Entrez Id: 84659
Gene Symbol: RNASE7
RNASE7
0.010 AlteredExpression disease BEFREE Cutaneous expression of the AMPs cathelicidin, human β-defensin-2 (HBD-2), lactoferrin, lysozyme, psoriasin (S100A7), koebnerisin (S100A15), and RNase 7 was upregulated in untreated acne vulgaris, whereas α-defensin-1 (HNP-1) was downregulated compared to controls. 24916439 2014
Entrez Id: 3605
Gene Symbol: IL17A
IL17A
0.030 Biomarker disease BEFREE Deficiency of vitamin D3 accompanied with higher IL-17 in an inverse pattern may have a possible role in active acne vulgaris. 30070012 2019
Entrez Id: 55869
Gene Symbol: HDAC8
HDAC8
0.010 AlteredExpression disease BEFREE Depletion of HDAC8 and HDAC9 in human sebocytes resulted in an enhanced cytokine response to TLR-2 activation that resembled the transcriptional profile of an acne lesion. 30737272 2019